Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorErasmus Medical Center
About this trial
The goal of this observational study is to better understand how chronic subdural hematoma (CSDH) progresses and how patients are treated and cared for. The study focuses on three main questions:
1. What are the characteristics of patients with CSDH when they are diagnosed? 2. What treatments do patients with CSDH receive? 3. What are the outcomes for patients with CSDH, including their functional ability, cognitive health, and neurological status?
Participants will receive their usual standard treatment. As part of the study, they will complete a brief telephone interview three months after their treatment.
Eligibility criteria
Qualifiers
Patients diagnosed with CSDH
18 years or older
Disqualifiers
Patients who do not consent to participate in the registry
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,500 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov